Actual Medicinal Product (AMP) - COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd)

Navigation

Name Details

Name Start Date End Date
Name Current Name COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials Start Date 01-09-2021 End Date
Previous Name Previous Name COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose solution for injection multidose vials Start Date 09-06-2021 End Date 31-08-2021
Abbreviated Name Abbreviated Name COVID-19 Vaccine Janssen 0.5ml inj multidose vials Start Date 30-11-2021

Summary

Discontinued
Licensed Route
Intramuscular
Availability Restrictions
Not available
Licensing Authority
Medicines - MHRA/EMA
EMA Indicator
EMA Monitoring

Codes

BNF Start Date End Date
Previous BNF 14040000 Start Date 09-12-2020 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39230211000001104 09-12-2020

Parent Products

Actual Medicinal Product Pack (AMPP) Information

Pack Size Indicative Price Discontinued
5 dose
50 dose